Ventriculoperitoneal shunt infection by Cryptococcus neoformans sensu stricto: Case report and literature review

Rev Iberoam Micol. 2022 Jan-Mar;39(1):16-20. doi: 10.1016/j.riam.2021.11.003. Epub 2022 Mar 2.

Abstract

Background: Cryptococcal ventriculoperitoneal shunt infection is known to occur due to an underlying infection in the patient rather than by nosocomial transmission of Cryptococcus during shunt placement. A case of chronic hydrocephalus due to cryptococcal meningitis that was misdiagnosed as tuberculous meningitis is described.

Case report: Patient details were extracted from charts and laboratory records. The identification of the isolate was confirmed by PCR-restriction fragment length polymorphism of the orotodine monophosphate pyrophosphorylase (URA5) gene. Antifungal susceptibility was determined using the CLSI M27-A3 broth microdilution method. Besides, a Medline search was performed to review all cases of Cryptococcus ventriculoperitoneal shunt infection. Cryptococcus neoformans sensu stricto (formerly Cryptococcus neoformans var. grubii), mating-type MATα was isolated from the cerebrospinal fluid and external ventricular drain tip. The isolate showed low minimum inhibitory concentrations for voriconazole (0.06mg/l), fluconazole (8mg/l), isavuconazole (<0.015mg/l), posaconazole (<0.03mg/l), amphotericin B (<0.06mg/l) and 5-fluorocytosine (1mg/l). The patient was treated with intravenous amphotericin B deoxycholate, but died of cardiopulmonary arrest on the fifteenth postoperative day.

Conclusions: This report underlines the need to rule out a Cryptococcus infection in those cases of chronic meningitis with hydrocephalus.

Keywords: Cryptococcus deneoformans; Cryptococcus neoformans sensu stricto; Cryptococcus neoformans var. grubii; Derivación ventriculoperitoneal; Diabetes; Infección; Infection; Tuberculosis; Ventriculoperitoneal shunt.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Cryptococcosis* / microbiology
  • Cryptococcus neoformans*
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use
  • Humans
  • Hydrocephalus* / drug therapy
  • Hydrocephalus* / surgery
  • Meningitis, Cryptococcal* / diagnosis
  • Meningitis, Cryptococcal* / drug therapy
  • Microbial Sensitivity Tests
  • Ventriculoperitoneal Shunt

Substances

  • Antifungal Agents
  • Fluconazole